LIVER TRANSPLANTATION Lyn Crellin Paediatric Liver Transplant ...
UHN Liver Centre...•Serial enzymes –AST, ALT, ALP, (GGT) •Serial liver function –bilirubin,...
Transcript of UHN Liver Centre...•Serial enzymes –AST, ALT, ALP, (GGT) •Serial liver function –bilirubin,...
1
Approach to Abnormal Liver Test: Approach to liver enzymes
Jordan J Feld MD MPH
Toronto Centre for Liver Disease
Sandra Rotman Centre for Global Health
Hemant Shah MD MScCHHPTE
Francis Family Liver Clinic
@hepatoMD
DisclosuresJordan Feld:
• Research: Abbott, Abbvie, Gilead, Janssen, Merck
• Consulting: Abbvie, Contravir, Gilead, Merck
Hemant Shah:
• Consulting Fees: Abbvie, Gilead, Merck, Intercept, Lupin
Learning Objectives
1. Appreciate the significance of different patterns of abnormal liver enzymes
2. Develop an approach to the initial work-up of abnormal liver enzymes in primary care
Outline
• Brief intro to ECHO
• Liver enzyme patterns
• Work-up for • Hepatocellular pattern
• Cholestaic pattern
• Mixed pattern
• Liver enzymes over 1000!
ECHO(Extension for Community
Health Outcomes)
The father of ECHO
2
Made in New Mexico
Primary Care MDs
Nurses
Other care providers
Project ECHO
- Linking PCPs to
specialists
- Facilitates
linkage to care
- Allows people to
be treated by
people and in
settings they
know & trust
Arora NEJM 2011 Perfected in Canada!
The Methods Use Technology to leverage scarce resources
Sharing “best practices” to reduce disparities
Case based learning to master complexity
Web-based database to monitor outcomes
Arora S, Acad Med. 2007 Feb;82(2): 154-60.
ECHO in Canada
• First proposed to do ECHO Hepatitis in Canada• Limited interest and no support from MOH
• Developed HepC Net program – Hemant Shah – similar model to support HCV treatment teams around Ontario
• 2014 – ECHO Pain • Chronic pain team led by Andrea Furlan
• Support from MOH
• Highly successful
• 2016 – Add ECHO Hepatitis + Arthritis…initially only HCV
• 2018 – expanded ECHO hepatitis to cover liver disease
The ECHO Hub Team
• Hepatology: Jordan Feld & Hemant Shah - Toronto
• Family Medicine/Addiction: Craig Kuhn - Niagara
• Nursing: Magdalena Kuczynski, Elizabeth Lee
• Pharmacist: Ruifen Su
• ECHO Team: Rhonda Mostyn – Project Manager
Ralph Fabico – Program Coordinator
Jane Zhao – Research Coordinator
Shamini Martin- Eduation Coordinator
Ashley Grilo – Admin Coordinator
The Sessions
• ‘Didactic session’• HCV curriculum – 15 topics
• Hub + ‘guest’ speakers – 40 min + discussion
• Case presentations• Community site
• Key points and clear question
• Discussion – community sites + hub
• Collective consensus on best strategies
• Follow-up of previous cases
• Pre + Post questionnaires + survey
After the Curriculum
• Welcome to join any time!
• Bring cases or just participate in the discussion
• With time…the goal is that everyone becomes a local HCV expert but still value in joining the sessions
• Updates from meetings
• New literature
• Challenging cases
3
Approach to Abnormal Liver Test: Approach to liver enzymes
Jordan J Feld MD MPH
Toronto Centre for Liver Disease
Sandra Rotman Centre for Global Health
Hemant Shah MD MScCHHPTE
Francis Family Liver Clinic
@hepatoMD
What do you call these tests?
• ALT
• AST
• ALP
• GGT
Liver enzymes NOT LFTs
ALT - Alanine aminotransferase | AST – Aspartate aminotransferase
ALP - Alkaline phosphatase | GGT - Gamma-glutamyl transferase
Why?56 yo man awaiting liver transplant
ALT 17
AST 27
GGT 43
ALP 93
“LFTs” are “Normal”!!
Actually – not true – LFTs VERY abnormalINR 2.4
Bilirubin 4.8 g/dL
Albumin 2.8 g/dL
INR – International normalized ratio | LFT – Liver function tests
Liver tests/enzymes ≠ LFTs• Liver Functions
• Synthesis:• Protein – Albumin, Clotting factors (INR)• Glucose – gluconeogenesis (only impaired very late)
• Metabolism:• Bilirubin conjugation• Ammonia breakdown (encephalopathy)• Drug/toxin breakdown
• (Portal Hypertension)• Ascites• Varices• Encephalopathy
Liver function tests: INR, albumin, bilirubin (direct)
What do the liver enzymes mean?
• Ongoing injury
• Hepatocellular injury• ALT (SGPT) – L for Liver specific (small amount muscle)
• AST (SGOT) – lots of other sources (RBC, muscle, heart)
• Normal for both lower than the labs!• Men – ALT 30
• Women – ALT 19
• Cholestatic/infiltrative injury or obstruction• ALP (alkaline phosphatase)
• GGT
Categorization• Most useful relative to upper limit of normal
• Hepatocellular pattern (ALT/ULN >> ALP/ULN)
• Cholestatic/infiltrative pattern (opposite)
• Mixed (ALT/ULN ≈ ALP/ULN)
• Helps with narrowing a broad differential
• Height & duration of elevation also important• Check trend i.e. historical labs
ULN - Upper Limit of Normal
4
Hepatocellular Pattern (ALT/AST)• Organization is key
• Infectious
• Toxic
• Metabolic
• Genetic
• Autoimmune
• Other
This should be the focus
Probably leave this stuff for us to do
Infectious
Screen EVERYONE!
• HBV (HBsAg, anti-HBc, anti-HBs)
• HCV (anti-HCV Ab)
Screen Selectively
• HAV – very high ALT (>1000, exposure hx) – IgM
• CMV/EBV – immunosuppressed, ALP elevated
Common enough
to screen even if
ALT normal
CMV – Cytomegalovirus | EBV - Epstein–Barr virus | IgM - Immunoglobulin G | HAV - Hepatitis A virus
Toxin
• Medications, medications, medications
• Almost any drug can do it
• Take a good history may have stopped the drug (ask about drugs in past 3 months)
• Antibiotics (Amox/Clav!!, minocycline, nitrofurantoin)
• Don’t forget herbals, OTC and recreational drugs –need to ask
Alcohol – how much is too much?
• History is everything
• AST>ALT (2:1) (+GGT)
• CAGE questionnaire
• Trust your patients (mostly)
• If ALT>500 not alcohol
alone
Men: 1-2 per day
Women: 1 per day
Avoid binge drinking
Avoid daily drinking
Metabolic – fatty liver
• ALT> AST (+ GGT)
• Metabolic risk factors
• DM, HTN, lipids
• Weight gain or loss
• Still screen for HCV,
HBV & ETOH – not
mutually exclusive!
• More to come…
Genetic• Hemochromatosis
• Not rare in Caucasians (think Vikings – northern Europe)• Fe Sat > 50%, Ferritin
• But both can be up in ETOH or Fatty liver disease• Again…not mutually exclusive!
• More likely if also DM, arthritis, bronzing of the skin…etc
• Wilson Disease• Screen all if < 30 and maybe all up to age 50• Ceruloplasmin• Bad to miss this – deadly disease that is treatable
5
Autoimmune??
• Diagnosis is not straightforward
• Variable presentation from asymptomatic liver test abnormalities to fulminant liver failure
• Useful diagnosis because it has a bad prognosis and it’s treatable!
• Start with IgG if high, follow with ANA, SMA (and LKM if children) and biopsy (or just refer!)
IgG - Immunoglobulin G | ANA - Antinuclear antibody
A few ‘general’ rules
• ALT>AST – most liver diseases• Viral hepatitis
• NAFLD/NASH
• Most drug induced liver injury
• AST>ALT• Alcohol – >2:1 ratio
• Ischemia (low flow or congestion)
• Wilson disease (hemolysis – 4:1)
• Cirrhosis!! (AST>ALT but <2:1)
So bottom line – ALT/AST
• Etiology Search• History – meds, alcohol & other drugs
• HBV, HCV for everyone, (HAV, other viruses in context)
• Fe Sat/ferritin for everyone
• (ceruloplasmin)
• (IgG – if persistent)
• Severity assessment• CBC – low platelets suggest cirrhosis or acute alcohol
• Bilirubin, INR, Albumin (if persistent)
• Ultrasound (if persistent)
What about high ALP?• First prove it’s from the liver GGT (usually up), ALP
isoenzymes• GGT is pretty useless on its own – VERY non-specific
(almost any liver disease) and inducible (by meds)
• Cholestatic• Extra-hepatic obstruction (stone/tumor)• Intrahepatic duct disease• Cholestasis (poor bile flow) – e.g. alcohol!!
• Infiltrative• Granulomatous• Mass / tumor
Cholestatic
• Rule out obstruction US usually adequate• If painless jaundice need to see pancreas (CT or MRCP)
• If no obstruction (this is where we come in…):• Large Ducts: Primary/Secondary Sclerosing Cholangitis
(stones, IgG4) MRCP
• Small Ducts: Primary Biliary Cholangitis, vanishing bile duct syndrome, portal biliopathy (PV thrombosis) biopsy
• Drugs (or alcohol) history +/- biopsy
Granulomatous/Infiltrative
• Granulomatous (biopsy)• Sarcoid
• TB/Fungal
• Schistosomiasis – even years after leaving endemic area
• Infiltrative (imaging +/- biopsy)• Lymphoma
• Mass lesion (HCC, mets, abscess, hydatid cyst)
6
High ALP – Work-up
History• Symptoms – may be absent
• Itch• Jaundice (dark urine –
useful for timing)• Pain, Fever (stones)• Constitutional symptoms
• DRUGS + Herbals
• Risk factors for TB, HCC
• History of IBD (PSC), past stones, surgery (chole), bone disease
Labs/Radiology• GGT – confirm liver (ie not
bone, placenta etc)
• Imaging – US• If high suspicion, CT/MR even
if US negative
• Etiology: • Anti-mitochondrial Ab (PBC)• Immunoglobulins (IgG, IgM)• Biopsy
Mixed Picture
• Similar approach to hepatocellular (AST/ALT)
• A few common ones:• Meds – antibiotics!
• Alcohol – acute alcoholic hepatitis
• Stones – AST/ALT up first followed by ALP (+/- Bili)
• Sepsis
• Viruses – CMV/EBV (not HBV, HCV)
• Rarer conditions (overlap syndromes etc)
A good list to remember – ALT>1000
1. Virus
2. Toxin
3. Vascular
4. Stone
5. Autoimmune hepatitis
Not alcohol (unless alcohol plus)
Viral Infection (ALT>1000)
• Hepatitis A to E• A – HAV IgM – only order if ALT very high &/or exposure• B – flare or acute infection• C – rare unless acute (if high suspicion, HCV RNA)• D – super-infection with HBV or flare• E – think Hep A (travel history)
• CMV/EBV• Rare to be >1000, usually cholestatic too (ALP up)
• HSV• Important – if you think of it, start the acyclovir!
• Rare – VZV, SARS, influenza, adenovirus
Toxin (ALT>1000)
• Medications, medications, medications
• Take a good history may have stopped the drug (ask about drugs in past 3 months)
• Acetaminophen classic
• Many others
• Don’t forget herbals, OTC and recreational drugs –need to ask
Vascular (ALT>1000)
• Forward flow – Shock Liver• Usually underlying cardiac disease
• Rapid increase and rapid normalization
• Mild affect on liver function (INR may go up transiently)
• Congestion• Acute Budd-Chiari
• Even severe heart failure (not very common)
7
Stone (ALT>1000)
• ALT and AST go up BEFORE ALP and Bilirubin
• Typically associated with pain +/- fever (others may be asymptomatic)
• Prompt normalization with passing of the stone
Autoimmune Hepatitis (ALT>1000)
• Not all that common but you have to think of it
• Diagnostic tests:• Quantitative immunoglobulins IgG
• ANA
• Smooth Muscle Antibody
• Liver Kidney Microsomal (Type II – children)
• Liver biopsy
When to refer…(or bring to ECHO)• Persistent enzyme elevation without a diagnosis • Management after a diagnosis
• HBV, HCV, AIH etc
• Signs of cirrhosis or liver failure (ascites, encephalopathy, variceal bleed)
• What we need:• Serial enzymes – AST, ALT, ALP, (GGT)• Serial liver function – bilirubin, INR, albumin• Serial CBC, Cr• Any work-up done – at least viral hep, Fe, IgG/Ab’s• Imaging – US usually adequate
Summary• Enzymes are not liver function tests!
• Categorize by pattern • Hepatocellular (ALT/AST)
• Cholestatic (ALP)
• Mixed (ALT & ALP)
• Directed work-up: history & physical, labs, imaging
Liver Disease Catches You By Surprise…
8
Liver May Look Normal Even with Cirrhosis
Stages F1-3 and even early F4 may “look normal” on imaging
A “normal” liver ultrasound does not exclude fibrosis and may miss cirrhosis
The Spectrum of Cirrhosis: From Subtle to Overt
Compensated Cirrhosis
Diagnosis subtle
Few or no symptoms
- Possibly fatigue
Subtle or no physical exam abnormalities
Subtle or no laboratory abnormalities
- Low platelet count, AST > ALT
Decompensated Cirrhosis
Diagnosis usually obvious
Complication(s) of cirrhosis
- Ascites/edema
- Variceal hemorrhage
- Encephalopathy
- Jaundice
Abnormal liver function
- Bilirubin
- Albumin
- INR
Tools to Assess Fibrosis
• Exam & radiology – very insensitive!!
• Laboratory tests• Liver enzymes (AST/ALT) may be normal even with
cirrhosis – not helpful
• Liver function (bilirubin, albumin, INR) normal until advanced cirrhosis
Tests suggesting advanced fibrosis/cirrhosis• Platelet count < 150 x 10E9/µl
• AST:ALT ratio > 1 (typically < 1 in HCV & most liver dx)
• Elevated IgG (polyclonal)
• (Abnormal bilirubin, INR, albumin late finding)
Simple Test: APRI
• Cirrhosis• Platelets fall• AST > ALT
• Very useful to exclude cirrhosis
• Low is good• <0.5 is good – 98% NPV for
cirrhosis!
• High is bad• >2.0 – worry about cirrhosis
• Caveat – AST high if active inflammation
AST/ULN x 100Platelet count
Castera et al., 2005
Liver Stiffness by Transient Elastography (Fibroscan)
Ultrasound-based technique
Determines liver “stiffness”
Correlates with liver fibrosis
No ceiling, ie, increases with worsening cirrhosis → predicts complications (eg, varices)
Simple to use – minimal training
Caveats: May fail with obesity
Influenced by inflammation – it falsely elevates measurements
Child-Pugh-TurcotteAssessing Severity of Cirrhosis
Lab 1 2 3INR (N<1.2) <1.7 1.7-2.2 >2.2Albumin (N>40) >35 28-35 <28
Bilirubin (N<17) <34 34-54 >54
ClinicalAscites none mild severeEncephalopathy none mild severe
Child’s CPT score Surgical Mortality SurvivalA 5-6 ~10% 10-15 yrs
B 7-9 ~30% 5 yrsC 10-15 ~80% 2 yrs
9
MELD – Very objective
• INR, Bilirubin, CreatinineBaseline MELD
10 Yr Mortality
<8 17%
8-10 18%
10-13 32%
>13 66%
MELD = (3.8 ln Bili (mg/dL)) + 11.2 (ln INR) + 9.6 (ln Creat (mg/dL)
(or use an online calculator!)
Bruno Am J Gastro 2009